Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

MilliporeSigma has signed an agreement with HistoCyte Laboratories, a Tyne, UK-based cell-line technology company, to be the exclusive multinational distributor of HistoCyte’s portfolio of cell-line reference products for immunohistochemistry and...

Minakem, the contract development and manufacturing division of Minafin, a Mont-Saint-Guibert, Belgium-based fine chemicals producer, plans to open a new closed-controlled environment high-containment production facility in August 2018 at the...

Marken, a Research Triangle Park, North Carolina-based provider of logistics and supply-chain services for clinical trial materials, is relocating its Chicago logistics hub into a new, larger facility near the Chicago airport. The new full-service...

Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has divested its rights, except in the US, for a potassium iodide product, ThyroSafe, to SERB SA, a Brussels, Belgium-headquartered specialty pharmaceutical...

Sarepta Therapeutics, a Cambridge, Massachusetts-based biopharmaceutical company focused on RNA-targeted therapeutics for rare neuromuscular diseases, has formed a long-term manufacturing partnership for gene-therapy with Brammer Bio, a Lexington,...

Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has agreed to acquire Sanofi’s contract manufacturing business for respiratory products in Holmes Chapel, England for approximately $60 million. The business...

AMRI, a contract research, development, and manufacturing organization, has signed a seven-year contract with the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to manufacture active...

Cambrex, an East Rutherford, New Jersey-based contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), plans to expand research and development (R&D) capabilities at its site in Paullo, Milan, Italy. The company is...

Vetter Pharma, a Ravensburg, Germany-headquartered contract development and manufacturing organization for aseptic filling and final packaging of injectables, has launched a challenge for developing solutions for injectables medicines that are...

Wasdell Group, a Newcastle, UK-headquartered contract development and manufacturing organization and contract packager, plans to invest £500,000 ($668,000) in a new analytical laboratory at its Newcastle site. The 1,200 square-foot facility will...

GE Healthcare has partnered with Xiangxue Pharmaceutical Co., a Guangzhou, China-headquartered pharmaceutical company, to provide GE’s FlexFactory platform, a semi-automated end-to-end manufacturing platform, to help scale up, digitize and...

Catalent Pharma Solutions reports on its supply pact with InterveXion, a Little Rock, Arkansas-headquartered clinical-stage biopharmaceutical company, to support the production of IXT-m200, InterveXion’s investigational anti-methamphetamine...

Cambrex, an East Rutherford, New Jersey-based contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), plans to begin a $5-million expansion of laboratory facilities at its site in Karlskoga, Sweden.   The company is...